Skip NavigationSkip to Content

Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI

  1. Author:
    Qasba, P. K.
    Ramakrishnan, B.
    Boeggeman, E.
  2. Author Address

    CCRNP, Struct Glycobiol Sect, NCI Frederick, Nanobiol Program, Frederick, MD 21702 USA. SAIC Frederick Inc, Basic Res Program, Frederick, MD USA.;Qasba, PK, CCRNP, Struct Glycobiol Sect, NCI Frederick, Nanobiol Program, Bldg 469,Room 221, Frederick, MD 21702 USA.;qasba@helix.nih.gov
    1. Year: 2006
  1. Journal: Aaps Journal
    1. 8
    2. 1
    3. Pages: E190-E195
  2. Type of Article: Review
  3. ISSN: 1550-7416
  1. Abstract:

    The availability of structural information on glycosyltransferases is beginning to make structure-based reengineering of these enzymes possible. Mutant glycosyltransferases have been generated that can transfer a sugar residue with a chemically reactive unique functional group to a sugar moiety of glycoproteins, glycolipids, and proteoglycans (glycoconjugates). The presence of modified sugar moiety on a glycoprotein makes it possible to link bioactive molecules via modified glycan chains, thereby assisting in the assembly of bionanoparticles that are useful for developing the targeted drug delivery system and contrast agents for magnetic resonance imaging. The reengineered recombinant glycosyltransferases also make it possible to (1) remodel the oligosaccharide chains of glycoprotein drugs, and (2) synthesize oligosaccharides for vaccine development.

    See More

External Sources

  1. WOS: 000236804800023

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel